Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 2611 AL 2625

Blood-Brain Barrier Opening with MRI-guided Focused Ultrasound Elicits Meningeal Venous Permeability in Humans with Early Alzheimer Disease

Mehta RI, Carpenter JS, Mehta RI, Haut MW, Ranjan M, Najib U, Lockman P, Wang P, D'haese PF, Rezai AR.

Radiology. 2021 Mar;298(3):654-662. doi: 10.1148/radiol.2021200643. Epub 2021 Jan 5.

Alzheimer's Disease, Neural Plasticity, and Functional Recovery

Mercerón-Martínez D, Ibaceta-González C, Salazar C, Almaguer-Melian W, Bergado-Rosado JA, Palacios AG.

J Alzheimers Dis. 2021;82(s1):S37-S50. doi: 10.3233/JAD-201178.

Functional nanoassemblies for the diagnosis and therapy of Alzheimer's diseases

Zhang L, Sun H, Chen Y, Wei M, Lee J, Li F, Ling D.

Wiley Interdiscip Rev Nanomed Nanobiotechnol. 2021 Jul;13(4):e1696. doi: 10.1002/wnan.1696. Epub 2021 Jan 18.

Multicenter randomized controlled trial of the effects of individual reminiscence therapy on cognition, depression and quality of life: Analysis of a sample of older adults with Alzheimer's disease and vascular dementia

Pérez-Sáez E, Justo-Henriques SI, Alves Apóstolo JL.

Clin Neuropsychol. 2022 Oct;36(7):1975-1996. doi: 10.1080/13854046.2021.1871962. Epub 2021 Jan 19.

Utilization of Specialized Geriatric Care Among Medicare Beneficiaries with Alzheimer's Disease and Related Dementia: An Observational Analysis

Nikpay S, Keohane LM, Cheng A, Braun K, Buntin M, Lipworth L, Stevenson D.

J Gen Intern Med. 2022 Feb;37(2):469-471. doi: 10.1007/s11606-020-06460-3. Epub 2021 Jan 22.

Cognitive Go/No-Go decision-making criteria in Alzheimer's disease drug development

Wessels AM, Edgar CJ, Nathan PJ, Siemers ER, Maruff P, Harrison J.

Drug Discov Today. 2021 May;26(5):1330-1336. doi: 10.1016/j.drudis.2021.01.012. Epub 2021 Jan 21.

Cognitive Effects of Aerobic Exercise in Alzheimer's Disease: A Pilot Randomized Controlled Trial

Yu F, Vock DM, Zhang L, Salisbury D, Nelson NW, Chow LS, Smith G, Barclay TR, Dysken M, Wyman JF.

J Alzheimers Dis. 2021;80(1):233-244. doi: 10.3233/JAD-201100.

Chalcone and its analogs: Therapeutic and diagnostic applications in Alzheimer's disease

Thapa P, Upadhyay SP, Suo WZ, Singh V, Gurung P, Lee ES, Sharma R, Sharma M.

Bioorg Chem. 2021 Mar;108:104681. doi: 10.1016/j.bioorg.2021.104681. Epub 2021 Jan 29.

The application of multifunctional nanomaterials in Alzheimer's disease: A potential theranostics strategy

Xu Y, Zhao M, Zhou D, Zheng T, Zhang H.

Biomed Pharmacother. 2021 May;137:111360. doi: 10.1016/j.biopha.2021.111360. Epub 2021 Feb 11.

A review on α-mangostin as a potential multi-target-directed ligand for Alzheimer's disease

Yang A, Liu C, Wu J, Kou X, Shen R.

Eur J Pharmacol. 2021 Apr 15;897:173950. doi: 10.1016/j.ejphar.2021.173950. Epub 2021 Feb 16.

Role of natural products for the treatment of Alzheimer's disease

Noori T, Dehpour AR, Sureda A, Sobarzo-Sanchez E, Shirooie S.

Eur J Pharmacol. 2021 May 5;898:173974. doi: 10.1016/j.ejphar.2021.173974. Epub 2021 Feb 27.

Alzheimer's disease

Scheltens P, De Strooper B, Kivipelto M, Holstege H, Chételat G, Teunissen CE, Cummings J, van der Flier WM.

Lancet. 2021 Apr 24;397(10284):1577-1590. doi: 10.1016/S0140-6736(20)32205-4. Epub 2021 Mar 2.

[« Forum Passerelle »: an opportunity for caregivers to meet the professionals of service and support in Alzheimer's disease and related diseases.]

Novais T, Vanhems E, Baritel M, Nier AC, Kyprianou A, Buisson B, Rouissi S, Richard G, Krolak-Salmon P, Coste MH, Loin L.

Geriatr Psychol Neuropsychiatr Vieil. 2021 Mar 1;19(1):102-109. doi: 10.1684/pnv.2021.0912.

Donanemab in Early Alzheimer's Disease

Mintun MA, Lo AC, Duggan Evans C, Wessels AM, Ardayfio PA, Andersen SW, Shcherbinin S, Sparks J, Sims JR, Brys M, Apostolova LG, Salloway SP, Skovronsky DM.

N Engl J Med. 2021 May 6;384(18):1691-1704. doi: 10.1056/NEJMoa2100708. Epub 2021 Mar 13.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias